Diabetic rats treated with Gliclazide, C. anthelminticum seed FO, and its fractions (i.e. HF, CF, and EF) showed significant reduction (p < 0.05) in the expression of IL-1β whereas; the levels of TNF-α decreased but not significantly. The gene discussed is IL1B; the disease is cystic fibrosis.